Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

154.27
+13.939.93%
Post-market: 151.85-2.4171-1.57%19:59 EDT
Volume:25.83M
Turnover:3.83B
Market Cap:61.59B
PE:-19.27
High:154.70
Open:140.25
Low:138.09
Close:140.34
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.92
T/O Rate:7.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:9.11
PE(LYR):-21.25

Loading ...

ETF Daily | MRNX Soars 352%; MRNY Surges 169%; TEMC, TEMT Jump 48%; NUGT Climbs 18%; Gold Miners and Biotech Lead

ETF Tracker
·
Aug 20

Moderna Shares Surge 177% on Promising Cancer Vaccine Data, Crushing Short Sellers with $5.5 Billion in Losses

Stock News
·
Aug 20

24H | Crypto Stocks Jump Again; Chip, Optical Communications Stocks Rebound; Moderna Pull Back After a 177% Surge

US Overnight
·
Aug 20

Movement Alert|Moderna, Inc. Declines 4.66% Overnight, Profit-Taking Follows Historic 177% Single-Day Surge on Cancer Vaccine Breakthrough

Market Focus
·
Aug 20

Review & Preview: Good Medicine

Dow Jones
·
Aug 20

Option Focus | Moderna's $525K Bear Call Spread and $1.67M Long-Dated Put Buy Reveal Institutions Bracing for a Major Downside Move

Option Witch
·
Aug 20

NASD Most Active Issues

Dow Jones
·
Aug 20

One Great Chart: Moderna Surge Makes S&P History

Dow Jones
·
Aug 20

Moderna price target raised to $89 from $39 at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

Movement Alert|Moderna, Inc. Rises 3.63% in After-Hours Trading, mRNA Melanoma Vaccine Phase III Trial Success Drives Continued Momentum

Market Focus
·
Aug 20

Moderna Closes up Nearly 177%, Best Performer in the S&P 500 Today

Dow Jones
·
Aug 20

US Stocks Close: Dow Rises Over 120 Points, SOX Drops 2%; Memory Stocks Lead Losses, SanDisk Falls 3.5%, Moderna Surges 177%

TradingKey
·
Aug 20

US Closing Bell | Unable to generate due to lack of news data

US Closing Bell
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20